Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Raymond

Showing results (251-260 of 345) with videos related to

Pageof 35
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 14, 1998
Preclinical and clinical strategies for development of telomerase and telomere inhibitorsS Sharma, E Raymond, H Soda, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 1997
Phase I study of daily times five topotecan and single injection of cisplatin in patients with previously untreated non-small-cell lung carcinomaE Raymond, H A Burris, E K Rowinsky, et al.
British Journal of Cancer|January 8, 2009
Safety and pharmacokinetics of paclitaxel and the oral mTOR inhibitor everolimus in advanced solid tumoursM Campone, V Levy, E Bourbouloux, et al.
Cancer|March 15, 1997
Bimonthly high dose leucovorin and 5-fluorouracil 48-hour continuous infusion in patients with advanced colorectal carcinoma. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD)K Beerblock, Y Rinaldi, T André, et al.
Advanced Materials (Deerfield Beach, Fla.)|March 12, 2026
Surface-Capped Protein Nanoparticles for Nonviral Gene DeliveryFjorela Xhyliu, Yao Yao, Yeongun Ko, et al.
Journal of the American Chemical Society|June 15, 2013
New functional handle for use as a self-reporting contrast and delivery agent in nanomedicineMathew P Robin, Anne B Mabire, Joanne C Damborsky, et al.
American Heart Journal|August 1, 1991
Percutaneous transluminal angioplasty involving internal mammary artery graftsA P Dimas, R R Arora, P L Whitlow, et al.
Cancer|March 15, 1997
Bimonthly high dose leucovorin and 5-fluorouracil 48-hour infusion with interferon-alpha-2a in patients with advanced colorectal carcinoma. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD)C Tournigand, C Louvet, A de Gramont, et al.
British Journal of Cancer|October 27, 2011
Phase I study of BIBF 1120 with docetaxel and prednisone in metastatic chemo-naive hormone-refractory prostate cancer patientsG Bousquet, J Alexandre, C Le Tourneau, et al.
Investigational New Drugs|March 30, 2013
A phase I schedule dependency study of the aurora kinase inhibitor MSC1992371A in combination with gemcitabine in patients with solid tumorsE Raymond, J Alexandre, S Faivre, et al.
Pageof 35

Showing results (251-260 of 345) with videos related to

Sort By:
Pageof 35
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 14, 1998
Preclinical and clinical strategies for development of telomerase and telomere inhibitorsS Sharma, E Raymond, H Soda, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 1997
Phase I study of daily times five topotecan and single injection of cisplatin in patients with previously untreated non-small-cell lung carcinomaE Raymond, H A Burris, E K Rowinsky, et al.
British Journal of Cancer|January 8, 2009
Safety and pharmacokinetics of paclitaxel and the oral mTOR inhibitor everolimus in advanced solid tumoursM Campone, V Levy, E Bourbouloux, et al.
Cancer|March 15, 1997
Bimonthly high dose leucovorin and 5-fluorouracil 48-hour continuous infusion in patients with advanced colorectal carcinoma. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD)K Beerblock, Y Rinaldi, T André, et al.
Advanced Materials (Deerfield Beach, Fla.)|March 12, 2026
Surface-Capped Protein Nanoparticles for Nonviral Gene DeliveryFjorela Xhyliu, Yao Yao, Yeongun Ko, et al.
Journal of the American Chemical Society|June 15, 2013
New functional handle for use as a self-reporting contrast and delivery agent in nanomedicineMathew P Robin, Anne B Mabire, Joanne C Damborsky, et al.
American Heart Journal|August 1, 1991
Percutaneous transluminal angioplasty involving internal mammary artery graftsA P Dimas, R R Arora, P L Whitlow, et al.
Cancer|March 15, 1997
Bimonthly high dose leucovorin and 5-fluorouracil 48-hour infusion with interferon-alpha-2a in patients with advanced colorectal carcinoma. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD)C Tournigand, C Louvet, A de Gramont, et al.
British Journal of Cancer|October 27, 2011
Phase I study of BIBF 1120 with docetaxel and prednisone in metastatic chemo-naive hormone-refractory prostate cancer patientsG Bousquet, J Alexandre, C Le Tourneau, et al.
Investigational New Drugs|March 30, 2013
A phase I schedule dependency study of the aurora kinase inhibitor MSC1992371A in combination with gemcitabine in patients with solid tumorsE Raymond, J Alexandre, S Faivre, et al.
Pageof 35